What drug interactions should I be aware of when taking upadacitinib?
Upadatinib, as a selectiveJanus kinase (JAK) inhibitor, has shown excellent results in the treatment of various autoimmune diseases such as rheumatoid arthritis and atopic dermatitis. However, drug-drug interactions may pose challenges to their efficacy and safety. So, how should patients be alert to and deal with the problem of combined use with other drugs while taking upadatinib?
First of all, it should be noted that when certain drugs are used together with upadatinib, its side effects may be enhanced or its therapeutic effect may be weakened. Such medications include, but are not limited to, phenytoin, antibiotics such as clarithromycin and rifampicin, and antifungals such as itraconazole and clotrimazole. Their interaction with upadatinib may lead to changes in drug efficacy, so special caution is required.
In addition, immunosuppressive drugs such as azathioprine, cyclosporine, and common non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, etc. may also affect the plasma concentration and efficacy of upadatinib. Especially for those patients who use NSAIDs, glucocorticoids at the same time or have a history of diverticulitis, the risk of gastrointestinal perforation will be significantly increased when taking upadatinib, so special vigilance is required.
To ensure medication safety, patients should fully inform their doctors about all medications they are taking, whether prescription drugs, over-the-counter drugs, vitamins or herbal products, while taking upadacitinib. Any addition or discontinuation of medications should be done under the guidance of a physician to avoid unnecessary drug interactions.
At the same time, patients should pay close attention to their physical condition and seek medical attention immediately if they develop new symptoms such as abdominal pain, fever, chills, nausea or vomiting to avoid worsening of the condition. Maintaining close communication with doctors and adjusting treatment plans in a timely manner are the keys to ensuring the therapeutic effect of upadatinib.
To sum up, when taking upadatinib, patients need to pay high attention to the interactions between drugs, strictly follow the doctor's instructions, and pay close attention to their physical condition to ensure the safety and effectiveness of the medication.
References:
https://www.drugs.com/rinvoq.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)